169 related articles for article (PubMed ID: 3618626)
1. Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
Crouse JR
Am J Med; 1987 Aug; 83(2):243-8. PubMed ID: 3618626
[TBL] [Abstract][Full Text] [Related]
2. Hypertriglyceridemia: a relative contraindication to the use of bile acid-binding resins?
Denke MA; Grundy SM
Hepatology; 1988; 8(4):974-5. PubMed ID: 3391527
[No Abstract] [Full Text] [Related]
3. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
Stein EA; Heimann KW
S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
[TBL] [Abstract][Full Text] [Related]
4. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G
Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910
[TBL] [Abstract][Full Text] [Related]
5. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
Glueck CJ; Fallat RW; Mellies M; Tsang RC
Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057
[TBL] [Abstract][Full Text] [Related]
6. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
Rose HG; Haft GK; Juliano J
Atherosclerosis; 1976; 23(3):413-27. PubMed ID: 178325
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia.
Glueck CJ; Mellies MJ; Dine M; Perry T; Laskarzewski P
Pediatrics; 1986 Aug; 78(2):338-48. PubMed ID: 3526270
[TBL] [Abstract][Full Text] [Related]
8. Changes in plasma lipoproteins in subjects treated with the bile acid-sequestering resin polidexide (Secholex).
Simons LA; Williams PF
Aust N Z J Med; 1976 Apr; 6(2):127-30. PubMed ID: 184773
[TBL] [Abstract][Full Text] [Related]
9. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
Day CE
Artery; 1990; 17(5):281-8. PubMed ID: 2396902
[TBL] [Abstract][Full Text] [Related]
10. Review of clinical studies of bile acid sequestrants for lowering plasma lipid levels.
LaRosa J
Cardiology; 1989; 76 Suppl 1():55-61; discussion 61-4. PubMed ID: 2653624
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
12. Weight loss improves lipoprotein lipid profiles in patients with hypercholesterolemia.
Davis TA; Anderson EC; Ginsburg AV; Goldberg AP
J Lab Clin Med; 1985 Oct; 106(4):447-54. PubMed ID: 4045301
[TBL] [Abstract][Full Text] [Related]
13. Results of colestipol therapy in Type II hyperlipoproteinemia.
Lees AM; McCluskey MA; Lees RS
Atherosclerosis; 1976; 24(1-2):129-40. PubMed ID: 182181
[TBL] [Abstract][Full Text] [Related]
14. Changes in plasma lipoprotein lipids in hypercholesterolaemic patients treated with the bile acid-sequestering resin, colestipol.
Clifton-Bligh P; Miller NE; Nestel PJ
Clin Sci Mol Med; 1974 Dec; 47(6):547-57. PubMed ID: 4375013
[No Abstract] [Full Text] [Related]
15. Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100.
Schmidt EB; Illingworth DR; Bacon S; Mahley RW; Weisgraber KH
Atherosclerosis; 1993 Jan; 98(2):213-7. PubMed ID: 8457260
[TBL] [Abstract][Full Text] [Related]
16. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
Glueck CJ; Ford S; Scheel D; Steiner P
JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098
[No Abstract] [Full Text] [Related]
17. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
Witztum JL; Schonfeld G; Weidman SW
J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
Seplowitz AH; Smith FR; Berns L; Eder HA; Goodman DS
Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502
[TBL] [Abstract][Full Text] [Related]
19. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
Crouse JR; Grundy SM
Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
[TBL] [Abstract][Full Text] [Related]
20. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
MaĆz A; Arteaga A; Villanueva CL; Velasco N; Acosta AM
Rev Med Chil; 1990 Sep; 118(9):1009-13. PubMed ID: 2152729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]